Salute e Benessere

atai Life Sciences to Participate in Upcoming June Investor Conferences

NEW YORK and BERLIN, June01, 2023(GLOBE NEWSWIRE) --atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming June Investor Conferences. Details of the company's participation are as follows: Jefferies 2023 Healthcare Conference Format: Corporate PresentationDate and Time: Friday, June 9 th, 9:00 a.m. ETLocation: New York, NYH.C. Wainwright 4 th...
Nasdaq GlobeNewswire
01/06/2023

Global Pediatric Epiphysiodesis Market to Surpass USD 23.94 Billion By 2031|…

Download PDF Sample here: https://growthmarketreports.com/request-sample/4684 Download PDF Sample here: https://growthmarketreports.com/request-sample/4684 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include technique, type, applications, end-users, and competitor analysis. This report also includes a complete...
PR Newswire
01/06/2023

Covis Announces Successful Completion of Its Previously Announced Financial…

Transaction supported by 100% of First Lien and 100% of Second Lien Lenders Results in material strengthening of the Company's balance sheet and liquidity profileExisting Equity Sponsors remain the majority shareholder in CovisCovis operationally and financially in a position to scale its business organically and inorganically ZUG, Switzerland, June01, 2023(GLOBE NEWSWIRE) -- Covis Finco Sarl (together with its subsidiaries “Covis” or the “Company”), today announced the...
Nasdaq GlobeNewswire
01/06/2023

Global Alpaca Fiber Market Expected to Make a Strong Comeback After the Pandemic…

As per the report published by Research Dive, the global alpaca fiber market is anticipated to generate a revenue of $1,201.5 million and grow at a CAGR of 3.5% over the forecast period from 2022 to 2031. As per the report published by Research Dive, theglobal alpaca fiber market is anticipated to generate a revenue of$1,201.5 millionand grow at a CAGR of 3.5% over the forecast period from 2022 to 2031. Segments of the Alpaca Fiber Market The report has divided the...
PR Newswire
01/06/2023

Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent…

-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (≥ 500 mg/dL) -- -- EddingPharm Now Working Towards Preparing for Commercial Launch of VASCEPA Across Mainland China Expected by Year-End -- DUBLIN, Ireland and BRIDGEWATER, N.J., June01, 2023(GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its commercial partner in China,...
Nasdaq GlobeNewswire
01/06/2023

WuXi Biologics to Increase Manufacturing Capacity in Germany

- As part of WuXi Biologics' global manufacturing network, a new drug product fill line is being installed at its Leverkusen site and the total biomanufacturing capacity is expected to double at its Wuppertal site - As part of WuXi Biologics' global manufacturing network, a new drug product fill line is being installed at its Leverkusen site and the total biomanufacturing capacity is expected to double at its Wuppertal site LEVERKUSEN and WUPPERTAL,Germany,June 1, 2023/PRNewswire/...
PR Newswire
01/06/2023

Navamedic ASA: Minutes of Annual General Meeting

For further information, please contact: For further information, please contact: Kathrine G. Andreassen, CEO, Navamedic, Mobile: +47 951 78 680 E-mail:kathrine@navamedic.com Lars Hjarrand, CFO, Navamedic, Mobile: +47 917 62 842 E-mail:lars.hjarrand@navamedic.com The following files are available for download: View original content: https://www.prnewswire.co.uk/news-releases/navamedic-asa-minutes-of-annual-general-meeting-301839843.html
PR Newswire
01/06/2023

Adtec Healthcare Limited, a leading Cold Plasma medical device manufacturer…

Adtec Healthcare's flagship medical device, the SteriPlas, has the most extensive collection of clinical trials and studies of any cold plasma company, is already CE marked and is being widely used across the UK and Europe. The purpose of this spin-out is to enable Adtec Healthcare to further expand the use of Cold Plasma in regions that have yet to adopt it in the clinic. Adtec Healthcare's flagship medical device, the SteriPlas, has the most extensive collection of clinical trials and…
PR Newswire
01/06/2023

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

"Pliaglis perfectly complements our range of aesthetic injectables. It is a further essential building block in our focused and differentiated aesthetics portfolio and proof of our full dedication to medical aesthetics. The planned launch of Pliaglis in our European markets and in Brazil in 2023 will further accelerate our growth," commented Andreas Prinz, CEO. "We are thrilled about our partnership with Crescita, together bringing this therapeutic option to healthcare…
PR Newswire
01/06/2023

ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement

ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. ERS holds over 100 patents worldwide. ERS, co-founded by Dr.Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. ERS holds over 100 patents worldwide. Based inVancouver,abmhas been a leader in genetic engineering tool development for the last...
PR Newswire
01/06/2023

Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca…

"The preclinical research groups of the Department of Medicine and Surgery of University of Milano-Bicocca are very pleased to include in the imaging facilities the nanoScan® 7T preclinical MRI scanner. With the system we will implement novel in vivo diagnostic procedures and better characterize the preclinical models of diseases under development based on established imaging features derived from clinical knowledge." "The preclinical research groups of the Department of Medicine…
PR Newswire
01/06/2023

DEBIOPHARM SHARES ONCOLOGY PROGRAM UPDATES AT ASCO 2023 FOR NOVEL WEE1…

"Both compounds are proposing innovative ways to tailor oncology treatments to patients. The theranostic pair Debio 0228/0328 aims to identify and benefit patients with CA IX-expressing tumors, starting with advanced ccRCC, PDAC and CRC. On the other hand, Debio 0123 continues to confirm its best-in-class potential in combination with carboplatin to overcome treatment resistance in solid tumors" expressed Dr. Angela Zubel, Chief Development Officer at Debiopharm. "Both compounds…
PR Newswire
01/06/2023

iOnctura to present research at leading scientific conferences in June 2023

American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA2-6 June 2023Poster title: 'First-in-human (FIH) phase I dose escalation study (Part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in Uveal Melanoma (Part B)'Presentation Time: 3 June 2023 at 08:00-11:00 CDT American Society of Clinical Oncology (ASCO) Annual Meeting,Chicago,USA2-6 June 2023Poster...
PR Newswire
01/06/2023

Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd

Under the terms of the acquisition, Ariceum will acquire 100% of the shares of Theragnostics in exchange for an upfront payment of $2.5 million in cash and milestone payments totalling up to $41.5 million. Under the terms of the acquisition, Ariceum will acquire 100% of the shares of Theragnostics in exchange for an upfront payment of$2.5 millionin cash and milestone payments totalling up to$41.5 million. Manfred Rüdiger, PhD, Chief Executive Officer of Ariceum Therapeutics, said :...
PR Newswire
01/06/2023

Belgian hospitals choose Sectra's public cloud service for enterprise…

"Moreover, the managed service and it being deployed in the cloud will give us more time to focus on the care of our patients," says Annelies Meyns, Head of ICT Applications at AZ Sint Jan. "Moreover, the managed service and it being deployed in the cloud will give us more time to focus on the care of our patients," saysAnnelies Meyns, Head of ICT Applications at AZ Sint Jan. The two hospitals, located in the city of Bruges, will utilize the Sectra One Cloud modules for…
PR Newswire
01/06/2023

SKF establishes global Product Category Rules for bearings to quantify…

PCR provide guidelines for evaluating the environmental impact of a particular product category, and the approval for bearings now allows for industry-wide Life Cycle Assessments (LCAs) to be conducted using standardized criteria. The results of these assessments can be used to create an EPD, which provides verified data about a product's environmental impact from raw material extraction to disposal, including energy usage, emissions, and resource consumption. PCR provide guidelines for...
PR Newswire
01/06/2023

Philogen Announces Clinical Trial Collaboration with MSD

The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with MSD's anti-PD-1 therapy, KEYTRUDA ®(pembrolizumab) in stage III and IV unresectable melanoma patients who previously failed treatment with checkpoint inhibitorsSiena, Italy, June 1 st, 2023- Philogen S.p.A., a clinical-stage biotechnology company focused on the development of innovative medicines based on tumor-targeting antibodies and small molecule...
Nasdaq GlobeNewswire
01/06/2023

Hansa Biopharma announces positive reimbursement decision for Idefirix…

A total of 419 kidney transplantations were performed in 2021 in Belgium, with the majority (86%) from deceased donors.1 Of more than 1,100 patients waiting for a kidney transplant in Belgium, it is estimated that one in ten are classified as highly sensitized, with limited or no access to a suitable donor organ. As of 2022, almost 11% of all patients on waiting list in Belgium have been on dialysis for more than 5 years 2, which relates to an increased mortality risk. 3,4 A total of 419…
PR Newswire
01/06/2023

Oxurion to Participate in Upcoming Conferences

Leuven, BELGIUM, Boston, MA, US –June 1 , 2023 – 8.00 AM CET –Oxurion NV (Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that the company will participate in three conferences in June: Knowledge for Growth 2023 AntwerpJune 1, 2023 Flanders Meeting & Convention Center AntwerpMichael Dillen, Chief...
Nasdaq GlobeNewswire
01/06/2023

GenesisCare Files for Voluntary Reorganisation to Advance Business…

Company to Pursue Separation of U.S. Business While U.S. Management Implements Turnaround Strategy Company to Pursue Separation of U.S. Business While U.S. Management Implements Turnaround Strategy SYDNEY,June 1, 2023/PRNewswire/ -- GenesisCare (or the "Company"), a leading integrated cancer care provider inthe United States,Australia,Spain, and theUnited Kingdom, announced a comprehensive transformation process intended to position the business for long-term growth...
PR Newswire
01/06/2023

Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan  

Sanofi launches2023 global Employee Stock Purchase Plan Paris , June 1 2023 .Sanofi launches Action 2023, its global employee shareholder plan, open to around 86,000 employees in 56 countries. The program builds on plans carried out since 2013 and demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve all employees, across all its territories, in the future development and results of the company.Paul Hudson Chief Executive...
Nasdaq GlobeNewswire
01/06/2023

Sandoz plans move to new central Basel headquarters by mid-2024, following…

Sandoz AG to remain based in Basel, Switzerland following proposed spin-off from Novartis Announcement of planned city-center HQ marks important milestone as Sandoz prepares to become independent company Basel, as a global life sciences center, ideally located to attract top talent Basel, June 1, 2023— Sandoz AG, a global leader in generic and biosimilar medicines, has announced the location of its future permanent headquarters in central Basel.The Sandoz AG headquarters...
Nasdaq GlobeNewswire
01/06/2023

Vivoryon Therapeutics N.V. to Participate in Upcoming Conferences

Vivoryon Therapeutics N.V. to Participatein Upcoming Conferences Halle (Saale) / Munich, Germany, June1 , 2023– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that the Company's management will participate in the following conferences:BIO...
Nasdaq GlobeNewswire
01/06/2023

Addex Shareholders Approve All Resolutions at Annual General Meeting

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland,June1 , 2023-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development (“the Company”), announced today that its shareholders approved, with a large majority, all of the proposals of the board of directors in its 2023 Annual General Meeting (AGM). The votes represented 32.24% of the company's outstanding...
Nasdaq GlobeNewswire
01/06/2023
Altri  Comunicati